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TRAPP is a highly conserved modular multi-subunit protein complex. Originally identified
as a “transport protein particle” with a role in endoplasmic reticulum-to-Golgi transport, its
multiple subunits and their conservation from yeast to humans were characterized in the
late 1990s. TRAPP attracted attention when it was shown to act as a Ypt/Rab GTPase
nucleotide exchanger, GEF, in the 2000s. Currently, three TRAPP complexes are known
in yeast, I, II, and III, and they regulate two different intracellular trafficking pathways:
secretion and autophagy. Core TRAPP contains four small subunits that self assemble to
a stable complex, which has a GEF activity on Ypt1. Another small subunit, Trs20/Sedlin,
is an adaptor required for the association of core TRAPP with larger subunits to form
TRAPP II and TRAPP III. Whereas the molecular structure of the core TRAPP complex
is resolved, the architecture of the larger TRAPP complexes, including their existence as
dimers and multimers, is less clear. In addition to its Ypt/Rab GEF activity, and thereby
an indirect role in vesicle tethering through Ypt/Rabs, a direct role for TRAPP as a vesicle
tether has been suggested. This idea is based on TRAPP interactions with vesicle coat
components. While much of the basic information about TRAPP complexes comes from
yeast, mutations in TRAPP subunits were connected to human disease. In this review we
will summarize new information about TRAPP complexes, highlight new insights about
their function and discuss current controversies and future perspectives.
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INTRODUCTION
Trafficking between intracellular compartments is mediated by vesicles and regulated by the
highly conserved Ypt/Rab GTPases, their nucleotide exchangers, GEFs, and their downstream
effectors (Lipatova et al., 2015a). Multi-protein complexes facilitate vesicle formation at donor
compartments, subsequent targeting, tethering and fusion with acceptor compartments. One such
complex, the transport protein particle TRAPP, acts as a Ypt/Rab GEF and possibly as a tether.
Yeast TRAPP was identified as a ten-subunit protein complex (∼800 kDa) that co-precipitated
with Bet3, which mediates endoplasmic reticulum (ER)-to-Golgi transport (Sacher et al., 1998,
2000). To date, eleven TRAPP subunits conserved between yeast and humans have been identified.
Seven subunits are small, 140–283 amino acids, and the rest are larger, 417–1435 residues. These
subunits are termed TrsN (N = size in kDa) or Bet3/5 in yeast, and TrappC (or TCP) 1–10 and
13, in mammalian cells. In yeast, these subunits assemble into three known complexes, TRAPP I,
II, and III. Six of the small subunits form TRAPP I or attach to it for assembly of the two other
complexes, while not much is known about the seventh small subunit Tca17. The large subunits
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are exclusive to either TRAPP II or TRAPP III complexes.
Two additional subunits, TrappC/TCP 11-12, are metazoan
specific and their TRAPP-related function will be discussed
(Table 1).
Based on similarities between the purified Ypt1 GEF (Jones
et al., 1998) and TRAPP, the activity of TRAPP as a Ypt GEF
was determined (Jones et al., 2000; Wang et al., 2000). The
idea that TRAPP acts as a tether to mediate vesicle docking
was proposed at the same time based on the requirement of
TRAPP for association of ER vesicles with the Golgi in a cell-
free system (Barrowman et al., 2000). Since 2000, while evidence
has accumulated regarding the importance of TRAPP subunits
in human health (Brunet and Sacher, 2014), many uncertainties
and controversies about the mechanisms of action of the TRAPP
complexes have piled up.
Here, we summarize current views on TRAPP complexes
structure, their function as Ypt/Rab GEFs and tethers, and
their connection to human disease. Most of the evidence
on the structure and function of TRAPP complexes comes
from yeast and pertains to mammalian cells, while studies
of human TRAPPs highlight their importance to human
health.
TABLE 1 | TRAPP complexes Subunits.
Subunit Group Yeast Trs/Bet
(aa)a
Human TrappC/TPC (alias)
(aa)a
Comments Disease Connections (References for recent
additions)b
Core TRAPP Bet5 (159) TrappC1 (Mum2) (145) Ypt1 binding Cancer
Bet3 (193) TrappC3 (180) Not foundc
Trs23 (219) TrappC4 (Synbidin) (219) Ypt1 binding Carcinogenesis (Weng et al., 2014)
Trs31 (283) TrappC5 (188) Not foundc
TRAPP I-associated Trs33 (268) TrappC6 a,b (159, 158) Alzheimer’s Disease
(Hamilton et al., 2011; Chang et al., 2015)
Adaptor Trs20 (175) TrappC2 (Sedlin) (140) Interacts with Trs85 &
Trs120
SEDT, Miscarriage (Wen et al., 2015)
Tca17d(152) TrappC2L (140) Not foundc
TRAPP III-specific Trs85 (698) TrappC8 (1435) Required for HPV entry (Ishii et al., 2013)
TRAPP II-specific Trs120 (1289) TrappC9 (NIBP) (1148) Cancer (Zhang et al., 2015); Intellectual disability (Khattak
and Mir, 2014); schizophrenia (McCarthy et al., 2014)
Trs130 (1102) TrappC10 (TMEM1) (1259) Cancer (Pongor et al., 2015)
Trs65 (560) TrappC13 (C5orf44) (417) Yeast TRAPP II
assembly, dimer
formation
Not foundc
Metazoan NA TrappC11 (C4orf41) (1133) mTRAPP IIIe Muscular dystrophy
NA TrappC12 (TCC-15) (735) mTRAPP IIIe
/Moonlighting in
mitosis
Not foundc
a(aa): number of amino acids.
bPrevious disease connections are summarized in Brunet and Sacher (2014).
cDisorders Not found: as of November 2015 in “Gene Cards database.”
dTca17 is grouped with its closest paralog Trs20 even though its role as an adaptor has not been shown.
eMammalian TRAPP III.
TRAPP COMPLEXES: COMPOSITION,
STRUCTURE, AND ARCHITECTURE
TRAPP Complex Composition
In early reports about TRAPP, ten of the eleven yeast TRAPP
subunits, except for Tca17, were found in a single high-molecular
weight complex (∼800 kDa) that co-precipitated with tagged
Bet3 (Sacher et al., 2000). Later, two complexes I and II, were
separated by gel filtration chromatography, where the larger
complex (∼1000 kDa) contains all the subunits of the smaller
complex (∼300 kDa), plus three large subunits (Sacher et al.,
2001). Similarly, all the mammalian TRAPP subunits can be
purified as a large complex (∼670 kDa) by co-precipitation with
a single core TRAPP subunit (Yamasaki et al., 2009).
The problem with assigning individual subunits to a specific
TRAPP complex based solely on their purification from cell
lysates is that TRAPP complexes oligomerize in cell lysates (Choi
et al., 2011). The fact that this oligomerization depends on
salt concentration or detergents suggests that it happens during
cell lysis or purification (Brunet et al., 2012, 2013). Homotypic
or heterotypic oligomerization can explain why the apparent
molecular weights of TRAPP I and TRAPP II are higher than
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their expected sizes based on their composition; e.g., the expected
size of TRAPP I is ∼170 kDa, the size of recombinant TRAPP I
purified from bacteria is∼170 kDa (Kim et al., 2006) as compared
to ∼300 kDa for the complex purified from yeast (Sacher et al.,
2001). Oligomerization can also explain the observation that
Trs85 fractionates with all the other TRAPP subunits (Sacher
et al., 2000) even though it does not seem to function with
TRAPP II. Therefore, assignment of individual subunits to
specific TRAPP complexes should be based not only on their
presence in purified complexes, but also on in vivo assays such
as phenotypic and co-localization analyses.
Currently, in yeast all the small subunits are assigned
to TRAPP I (Sacher et al., 2008). However, even though a
recombinant yeast TRAPP I complex can be purified with six
small subunits in stoichiometry of 2:1 Bet3 to each of the other
five subunits (Kim et al., 2006), it is not clear whether two of these
subunits, Trs20 and Trs33, function as part of this complex. Trs20
plays a role as an adaptor and is required for the assembly of the
large TRAPP complexes: the association of TRAPP I with Trs120
for TRAPP II assembly (Taussig et al., 2013), and with Trs85 for
TRAPP III assembly (Brunet et al., 2013; Taussig et al., 2014).
However, it is currently unknown whether Trs20 is required for
the function of TRAPP I. Tca17, a paralog of Trs20, also does
not have a known function with TRAPP I (see below). Unlike the
other small TRAPP subunits, Trs33 is not required for yeast cell
viability or secretion. A role for Trs33 in the context of TRAPP I
is currently unknown, and it is required for TRAPP II assembly
only when Trs65 is absent (Tokarev et al., 2009). Therefore, in
Table 1, Trs33 is listed as a TRAPP I-associated subunit. TRAPP
I cannot be separated from the mammalian TRAPP II and its
existence in vivo in mammalian cells is currently in question
(Barrowman et al., 2010).
The assignment of Trs120, Trs130, and Trs65 as TRAPP II-
specific subunits in yeast is based on their purification with this
complex and on mutational analysis (Sacher et al., 2001; Liang
et al., 2007). Trs85, in spite of its co-purification with TRAPP I, is
considered as a TRAPP III-specific subunit in yeast (Sacher et al.,
2008).
A single TRAPP complex purified frommammalian cell lysate
contains all the known subunits, including the Trs85 ortholog,
TrappC8 (Scrivens et al., 2011). However, based on genetic
interaction maps, two TRAPP complexes were suggested to exist
in mammalian cell: TRAPP II, which contains core TRAPP plus
TrappC9-10, and TRAPP III, which contains core TRAPP plus
TrappC8, 11-13 (Bassik et al., 2013). The inclusion of TrappC13,
the homolog of Trs65, in the mammalian TRAPP III differs
from its inclusion in the yeast TRAPP II complex. Importantly,
there is currently no evidence for the existence of TRAPP I in
mammalian cells.
Identifying New TRAPP Subunits
A number of proteins were suggested to be TRAPP subunits.
Tca17 (TRAPP complex associated) and its mammalian ortholog
TrappC2L (TrappC2-like) were identified as sub-stoichiometric
components of purified TRAPP that have sequence similarity
to Trs20/Sedlin, and may play a role in in TRAPP assembly
or stability (Montpetit and Conibear, 2009; Scrivens et al.,
2009). Two metazoan-specific subunits, TrappC11, which is
distantly related to Trs130/TrappC10, and TrappC12, were
identified based on their co-fractionation with TRAPP and effect
of their depletion on ER-to-Golgi transport (Wendler et al.,
2010; Scrivens et al., 2011). A role for TrappC12, renamed
TRAMM, without the rest of the TRAPP complex, was recently
shown in mitosis (Milev et al., 2015). While it is possible that
TrappC12 has a moonlighting function inmitosis, it suggests that
proteins that associate with TRAPP are not necessarily TRAPP
subunits. Therefore, additional criteria should be considered
before assigning a Trs or TrappC number for new yeast and
mammalian subunits, respectively.
TRAPP Subunit Structure
The crystal structure of all the small yeast and mammalian
TRAPP subunits has been resolved. Structurally, the subunits fall
into two groups. Members of the Bet5 group, which also includes
Trs20, Trs23, and Tca17, have a longin-domain (LD) fold (α–β–α
sandwich), which is involved in protein-protein interactions and
was suggested to form a LD-LD platform for GTPase binding
(Levine et al., 2013). Specifically, in TRAPP I, Bet5 and Trs20
form a LD-LD platform for Ypt1 binding (Cai et al., 2008).
Members of the Bet3 group, which also includes Trs31 and Trs33,
have similar structures (α/β-plait topology) despite low sequence
similarity (Kümmel et al., 2005), and hetero-dimerize with Bet3
in the context of TRAPP I (Kim et al., 2006). Currently, the
structures of the large TRAPP subunits are not resolved.
TRAPP Complex Architecture
While the subunit organization of TRAPP I was solved by
crystallography, the architecture of the larger complexes was
suggested based on single-particle electron microscopy (EM) and
mutational analyses (Figure 1).
TRAPP I Architecture
Recombinant core yeast TRAPP complex can self assemble
when at least four subunits are co-expressed in bacterial cells:
Bet3, Bet5, Trs23, and Trs31 (Table 1). The three-dimensional
structure of core TRAPP has been solved by crystallography.
The∼135 Å-long and 35–70 Å-wide cylinder contains two copies
of Bet3 and one copy of each of the other three subunits (Cai
et al., 2008). Two additional small subunits, Trs33 and Trs20, can
attach at the two ends of the yeast core TRAPP, if co-expressed
with the core subunits, to form the six-subunit TRAPP I. This
complex is ∼180 Å long and 65 Å wide. An atomic model
for subunit organization of TRAPP I was suggested by single
particle EM analysis and docking of crystal structures of two sub-
complexes of mammalian TRAPP I. The two Bet3 copies have
similar orientations to the same flat side of the complex, which
contains both acidic and basic patches and is thought to face the
membrane (Kim et al., 2006). Ypt1 binds the opposite, mostly
acidic, side of TRAPP I (Kim et al., 2006; Cai et al., 2008).
Yeast TRAPP III Architecture
The architecture of the yeast TRAPP III was suggested based
on negative EM staining and docking of the atomic model of
TRAPP I (see above) in the EM density map of TRAPP III.
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FIGURE 1 | Yeast TRAPP complexes. (A) Core TRAPP, which contains four small subunits with two copies of Bet3 (3a and 3b), self assembles, binds Ypt1 through
Bet5 and Trs23 and acts as a Ypt1-GEF. The diagram is based on the published structure of core TRAPP in a complex with Ypt1 (Cai et al., 2008). (B) TRAPP I
contains core TRAPP, Trs20 and Trs33. However, it is not clear that the presence of the latter two subunits (in gray) is required for its function. The diagram is based on
the published EM structure of core TRAPP subunits with Trs33 or Trs20 (Kim et al., 2006). (C) TRAPP III contains core TRAPP, Trs20 (orange), which is required for its
assembly with Trs85 (green) and its function in autophagy. A role for Trs33 (in gray) in this complex has not been shown. The diagram is based on the published
architecture and mutational analysis of TRAPP III (Tan et al., 2013; Taussig et al., 2014). (D) TRAPP II contains TRAPP I, including Trs20 (orange) and Trs33, and three
large subunits: Trs120, Trs130, and the non-essential Trs65. Trs20 is required for the interaction of TRAPP I with Trs120, and either Trs65 or Trs33 are required for
assembly of TRAPP II in vivo. TRAPP II is depicted here as a dimer (see discussion in the text). The cubes representing the subunits are roughly proportionate to their
size; numbers stand for TrsN, except for Bet3 and Bet5. Approximate length (Å) is based on crystal structure for core TRAPP and negative staining EM for the other
complexes (see text).
According to this model, Trs85 attaches to TRAPP I through
Trs20, to form an elongated crescent shaped complex with
approximate dimensions of 230 × 68 × 46 Å. Ypt1 binds to the
same position as in TRAPP I (Tan et al., 2013). The EM structure
is supported by mutational analysis of Trs20, which identified
the Trs20 interface where Trs85 attaches to TRAPP I (Taussig
et al., 2014). However, the structure of Trs85 and its interface with
TRAPP I are not known.
TRAPP II Architecture
The architecture of TRAPP II purified from yeast cell lysates
was proposed based on single-particle EM and docking the
atomic model of TRAPP I (see above). The suggested ∼225 ×
250 Å diamond-like structure is of a dimer in which the
TRAPP II-specific subunits are sandwiched between two anti-
parallel TRAPP I complexes (Yip et al., 2010). Currently, there
is no evidence that dimerization of TRAPP II is required for its
role in secretion to maintain cell viability, since Trs65, which is
required for this dimerization, is not essential for cell viability.
Moreover, in this model, the assignments of Trs120 and Trs130 to
the Trs33 and Trs20 sides of TRAPP I, respectively, do not agree
with existing mutational analyses. We have found that whereas
Trs20 is required for the attachment of Trs120 to TRAPP I, Trs33
plays a role in the interaction of Trs130 with TRAPP I (Tokarev
et al., 2009; Taussig et al., 2013), thus placing Trs120 and Trs130
to the opposite sides of TRAPP I when compared to the EM-
based structure (Figure 1D). Considering these disagreements,
the uncertainty regarding the significance of the dimer, and the
fact that structural information is currently not available for the
large subunits of TRAPP II, we conclude that the architecture of
TRAPP II is still unclear.
TRAPP COMPLEXES CELLULAR
FUNCTION
Yeast TRAPP I-III
In yeast, based on effect of mutations in subunits of TRAPP I,
II and III, it is now accepted that TRAPP I acts at early Golgi,
TRAPP II in late Golgi, and TRAPP III in autophagy (Figure 2).
The cellular function of the different TRAPP complexes can be
inferred from whether they are essential for cell viability. In
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FIGURE 2 | The role of TRAPP complexes and their Ypt substrates in
yeast intra-cellular trafficking. In the exocytic pathway (top), TRAPP I
activates Ypt1 to regulate ER-to-Golgi transport, whereas TRAPP II activates
Ypt31/32 to regulate Golgi-to-PM transport. In autophagy (bottom), a cellular
recycling pathway (in green), TRAPP III activates Ypt1 to regulate the assembly
of PAS, the first step of autophagy. PAS is required for the formation of the
double-membrane autophagosome (AP), which delivers cargo for degradation
in the lysosome. See discussion in the text.
addition to the core TRAPP subunits, the Trs20 adaptor and
the two TRAPP II-specific subunits are essential for cell viability,
whereas the others, Trs33, Trs65, and Trs85, are not (Table 2).
In the secretory pathway, cargo is delivered from the ER,
through the Golgi apparatus, to the plasma membrane (PM).
A set of Sec proteins that mediate the different steps of this
pathway are essential for cell viability (Feyder et al., 2015). The
essential TRAPP subunits make up the two TRAPP complexes, I
and II, which function in the secretory pathway. The assignment
of TRAPP I and TRAPP II to early and late Golgi, respectively,
is based on mutation analysis. Specifically, whereas conditional
mutations in Bet3 and Bet5, which are present in all TRAPP
complexes, elicit an ER-to-Golgi as the first blocked transport
step, mutations in the TRAPP II-specific subunits Trs130 and
Trs120 result in a late Golgi transport block (Sacher et al., 2001).
Autophagy is a cellular recycling process in which excess
or damaged cellular components are delivered for degradation
in the lysosome via a double-membrane organelle termed
autophagosome (AP). This process starts with the formation
of the pre-autophagosomal structure, PAS, by a set of ∼40
autophagy-specific proteins, Atgs. Usually there is one PAS per
cell. Atgs are not required for cell viability during normal
cell growth, but only during stress, e.g., nitrogen starvation
(Weidberg et al., 2011). The TRAPP III-specific subunit, Trs85,
which is not essential for cell viability, was instead shown to play
a role in selective and non-selective autophagy (Meiling-Wesse
et al., 2005; Nazarko et al., 2005).
While currently it is not clear how TRAPP complexes localize
to the compartment on which they function, Golgi or AP, there
are conflicting reports about the relationship between Trs85 and
Atg9 and localization to PAS. Atg9 is the only integral membrane
Atg and Atg9 vesicles are considered to bring the membrane
component of the PAS (Weidberg et al., 2011). Trs85 and Atg9
co-localize on PAS, and also in multiple puncta in the cytosol
(Lipatova et al., 2012). Based on co-immuno-precipitation and
yeast-two hybrid interaction of Trs85 and Atg9 (neither shows
a direct interaction), and the finding that Trs85 is not recruited
to PAS in atg91 mutant cells, it was suggested that Atg9 brings
TRAPP III to PAS (Kakuta et al., 2012). While this is a possibility,
the problem is that in atg91 mutant cells there is no membrane
in PAS and therefore no place for Trs85 or TRAPP to attach to. In
contrast, it was proposed that TRAPP III plays a role in bringing
Atg9 to PAS (Shirahama-Noda et al., 2013). Hopefully, future
experiments will help resolve this issue.
Mammalian Golgi TRAPP
In yeast, TRAPP subunits required for secretion are essential for
cell viability. In three recent screens of ∼20,000 human genes,
about 2000 essential genes were identified (Blomen et al., 2015;
Hart et al., 2015; Wang T. et al., 2015), with about a third having
yeast essential orthologs (Blomen et al., 2015). We looked for
the essentiality of TRAPP subunits in these three studies, which
together analyzed 10 cell lines in 11 independent gene-trap or
CRISPR/Cas9 screens (Table 2). The four core TRAPP complex
subunits, TrappC1 (Bet5), TrappC3 (Bet3), TrappC4 (Trs23), and
TrappC5 (Trs31), which are essential in yeast, are also essential
in human cells. Two subunits not essential in yeast are also not
essential in human cells: Trs33/TrappC6A/B (even though A and
B could be supplementing for each other), and Trs65/TrappC13.
The outliers are three genes essential in yeast but not in human
cells: the adaptor Trs20/TrappC2, and the two TRAPP II-specific
subunits, Trs120/TrappC9 and Trs130/TrappC10. In yeast, these
three proteins assemble with core TRAPP to make TRAPP II,
which is required for secretion. One subunit, Trs85, is not
essential for yeast cell viability, whereas the human ortholog
TrappC8 is; however, the similarity between these two subunits
is very limited. Of the two metazoan-specific TRAPP subunits,
one is essential, TrappC11, and one is not, TrappC12. Thus, more
studies would be essential to interpret the reason for essentiality
of the different TRAPP subunits in human cells.
Based on themigration of all the mammalian TRAPP subunits
in a single high-molecular weight peak (∼670 kDa) (Yamasaki
et al., 2009), the currently dominating idea is that TRAPP
II is the only mammalian Golgi TRAPP (Barrowman et al.,
2010). However, because the expected size of individual TRAPP
complexes is much smaller than the apparent ∼670–800 kDa
size of complexes purified from cell lysates, and because purified
TRAPP complexes tend to oligomerize (Choi et al., 2011; Brunet
et al., 2012), we suggest that the jury is still out regarding
the existence of more than one mammalian Golgi TRAPP
complex.
Mammalian TRAPP II was suggested to function in ER-to-
Golgi transport based on the localization and knockdown effect
of the TRAPP II-specific subunit mTrs130 (Yamasaki et al.,
2009). On the other hand, roles for mTRAPP II and Rab11
(a Ypt31 homolog), together with the Golgi-to-PM regulators
Rab8 and Rabin8 (a Sec2 homolog), were shown in human cells
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TABLE 2 | TRAPP Subunit Essentially.
Subunit Yeast Essential Human Essential Essential Essential Essential
Group Trs/Bet In Yeast TrappC Hart et ala Blomen et alb Wang et alc in Humand
Core TRAPP Bet5 Yes TrappC1 Yes (5/5) Yes (2/2) Yes (4/4) Yes (11/11)
Bet3 Yes TrappC3 Yes (5/5) Yes (2/2) No (1/4) Yes (8/11)
Trs23 Yes TrappC4 Yes (4/5) Yes (2/2) ? (2/4) Yes (8/11)
Trs31 Yes TrappC5 Yes (5/5) ? (1/2) Yes (4/4) Yes (10/11)
Others Trs33 No TrappC6A
TrappC6B
No (0/5)
No (0/5)
No (0/2)
No (0/2)
No (0/4)
No (0/4)
No (0/11)
No (0/11)
Trs20 Yes TrappC2 (Not tested) No (0/2) No (0/4) No (0/6)
Tca17 No TrappC2L No (1/5) No (0/2) No (1/4) No (2/11)
Trs85 No TrappC8 Yes (4/5) Yes (2/2) Yes (3/4) Yes (9/11)
Trs120 Yes TrappC9 No (0/5) No (0/2) No (1/4) No (0/11)
Trs130 Yes TrappC10 No (0/5) No (0/2) No (0/4) No (0/11)
Trs65 No TrappC13 Yes (3/5) No (0/2) No (0/4) No (3/11)
Metazoan NA NA TrappC11 Yes (5/5) Yes (2/2) Yes (4/4) Yes (11/11)
NA NA TrappC12 No (0/5) No (0/2) No (0/4) No (0/11)
aTested in 5 cell lines (number of cell lines in which the gene is essential/number of cell lines tested; Hart et al., 2015).
bTested in 2 cell lines (number of cell lines in which the gene is essential/number of cell lines tested; Blomen et al., 2015).
cTested in 4 cell lines (number of cell lines in which the gene is essential/number of cell lines tested; Wang T. et al., 2015).
dConsensus: Yes, if gene is essential in at least 6/11 cell lines tested in the three studies.
Red: Genes essential in yeast but not in human cells.
Green: Gene essential in human cells, not in yeast.
during primary cilia assembly (Westlake et al., 2011). These
conflicting findings highlight the uncertainty regarding the roles
of mammalian Golgi TRAPP complexes.
Mammalian TrappC2/Sedlin
Mutations in SEDL, the gene that encodes Sedlin, were
implicated in the cartilage disease SEDT (Table 1). Knockout of
Sedlin/TRAPPC2 showed that the gene is not essential for cell
viability (Table 2). Sedlin knockdown specifically affects export
of procollagen, a large cargo that cannot fit into COPII vesicles,
from the ER into megacarriers. While Sedlin probably does it
in the context of TRAPP because mBet3 is also required for
this process (Venditti et al., 2012), it is not clear which TRAPP
complex is involved in this process.
Mammalian TRAPP III
While there is currently no direct evidence for the existence of
TRAPP III or for a role of TrappC8 in autophagy, TrappC8 was
identified in a proteomic study as a component of the human
autophagy interaction network (Behrends et al., 2010). Unlike
yeast, based on genetic interaction maps and co-IP, a role for the
mammalian TRAPP III was proposed in ER-to-Golgi transport
together with COPII vesicles (Bassik et al., 2013). In addition,
TrappC8 was shown to be required for cell entry of the human
papilloma virus, implying its role in endocytosis (Ishii et al., 2013)
and for ciliogenesis (Schou et al., 2014). Thus, the conservation of
a role for TRAPP complexes in autophagy is still unclear.
Plant TRAPPs
Plants have orthologs for all the TRAPP I and TRAPP II subunits
essential in yeast and the TRAPP III-specific subunit Trs85
(Thellmann et al., 2010). As in yeast, TRAPP II was implicated
in a late Golgi transport step together with the exocyst (Rybak
et al., 2014). The functions of TRAPP I and TRAPP III in plants
are currently unknown.
TRAPP COMPLEXES AS Ypt/Rab GEFs
Golgi TRAPPs
Identification of GEFs for individual Ypt/Rabs is not
straightforward because, although individual GEFs are conserved
through evolution, they do not share obvious similarities with
GEFs for other Ypt/Rabs. The implication of TRAPP as a GEF
for Ypt1 was inspired by biochemical similarities observed
independently in different labs between a purified Ypt1 GEF and
the TRAPP complex (Jones et al., 1998; Sacher et al., 1998). Soon
after, TRAPP was identified as a Ypt1 GEF (Jones et al., 2000;
Wang et al., 2000). While the idea that TRAPP acts as a Ypt/Rab
GEF is well-established, the Ypt-GEF specificity of individual
TRAPP complexes has been under debate.
Using biochemical and genetic analyses, including GEF
activity, co-precipitation assays, the effect of TRAPP mutations
on Ypt cellular localization and high-copy suppression of
mutations, we have shown that TRAPP I acts as a GEF on Ypt1
whereas TRAPP II is a Ypt31/32 GEF (Morozova et al., 2006).
In contrast, based on lack of GEF activity of purified TRAPP
II on Ypt31/32 (Wang and Ferro-Novick, 2002), inability of
GST-tagged Ypt31/32 to pull-down a TRAPP II-specific subunit
(Yip et al., 2010), and a proposed localization and function
of Ypt1 at the late Golgi (Sclafani et al., 2010), the view that
all TRAPP complexes act on Ypt1 throughout the Golgi was
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promoted (Barrowman et al., 2010). However, recently this view
was disputed at multiple levels. First, the observed phenotypes
of YPT1 mutations assigning it a role in the late Golgi were
shown to result from a defect in ER-phagy and not in late Golgi
transport (Lipatova et al., 2013). Second, localization of Ypt1 and
Ypt31 to opposite sides of the Golgi, early and late, respectively,
was recently established (Kim et al., 2016). Third, the activity
of TRAPP II as a GEF for the Ypt31 ortholog RabERAB11 at
the trans Golgi was shown in Aspargilus nidulans, a filamentous
fungus, both in vivo and in vitro (Pinar et al., 2015). Therefore,
the current model for TRAPP complexes and their Ypt substrates
in yeast depicts that TRAPP I and TRAPP II activate Ypt1 and
Ypt31/32, respectively, on the two ends of the Golgi (Figure 2).
Support for the current model comes from two metazoan
model systems. First, in Drosophila, the Trs120 homolog bru was
shown to function in the late Golgi, to interact with Rab11, a
Ypt31/32 homolog, and to affect the latter’s cellular localization
(Robinett et al., 2009). Second, in Arabidopsis, TRAPP II was
functionally linked to the Ypt31 plant ortholog Rab-A, but not to
the Ypt1 ortholog Rab-D (Qi et al., 2011). These results support
the idea that TRAPP II acts as a Ypt31/32 GEF not only in yeast.
The mammalian Golgi TRAPP II (see above) was shown to act
in vitro as a Rab1, but not Rab11, GEF (Yamasaki et al., 2009).
While the GEF specificity of yeast and mammalian TRAPPs
might differ, we suggest that more research is needed to resolve
this issue.
TRAPP III
In yeast, Ypt1 is required for stress-induced and the selective
autophagy pathway CVT (cytoplasm-to-vacuole) (Segev and
Botstein, 1987; Lynch-Day et al., 2010; Lipatova and Segev, 2012;
Lipatova et al., 2013). The idea that the Trs85-containing TRAPP
III complex activates Ypt1 in autophagy is based on the following
evidence: First, Trs85 is required for bringing Ypt1 to PAS
(Lynch-Day et al., 2010). Second, using bimolecular fluorescence
complementation (BiFC), Ypt1 and Trs85 were shown to interact
on PAS (Lipatova et al., 2012, 2015b). Third, overexpression of
Ypt1 can suppress the autophagy defects of bet3 and trs851
mutant cells (Lipatova et al., 2012; Zou et al., 2015). In addition
to the BiFC interaction of Ypt1 and Trs85 on PAS, they also
interact on Atg9 membranes. Once Ypt1 is activated on Atg9
membranes, it recruits Atg proteins to form PAS (Lipatova et al.,
2012). Recruitment of two Atgs requires Ypt1, Atg1 and Atg11;
only the last was shown to be a bona fide Ypt1 effector (Lipatova
et al., 2012; Wang et al., 2013).
In mammalian cells, the orthologs of Ypt1 and Trs85,
Rab1 and TrappC8, respectively, were implicated in autophagy
(Behrends et al., 2010; Zoppino et al., 2010). However, because
the similarity between Trs85 and TrappC8 is very low, and
because TrappC8 was also suggested to play a role in ER-to-Golgi
transport (Bassik et al., 2013), the connection of the mammalian
TRAPP III complex to autophagy is currently not clear.
TRAPP COMPLEXES AS TETHERS
Tethers are proteins that can bridge two membranes and
thereby capture vesicles (∼500–1000 Å diameter) by an
appropriate acceptor compartment. They are thought to bring
two membranes into∼300 to>2000 Å proximity (Bröcker et al.,
2010) and to facilitate vesicle uncoating and SNARE complex
formation. SNAREs bring membranes to ∼140 Å proximity and
mediate membrane fusion (Hanson et al., 1997). Tethers can
be long coiled-coil proteins or multisubunit-tethering complexes
(MTCs), which typically interact with GTPases in their GTP-
bound form, namely, they are downstream effectors of GTPases
(Yu and Hughson, 2010).
While accumulation of vesicles when a putative tether is
depleted agrees with the idea that this protein could be a tether,
it does not prove this idea because the effect can be indirect or
the protein might act in any sub step between vesicle formation
and tethering, e.g., vesicle motility. Two types of assays have been
used to establish tethering activity. First, an in vitro reconstitution
assay was used to show that theHOPS complex is a tether (Hickey
and Wickner, 2010). Second, an in vivo assay was used to show
that directing the exocyst subunit Sec3 to the mitochondria,
results in tethering of secretory vesicles to this compartment (Luo
et al., 2014). Such assays have not been used for TRAPP yet.
The notion that TRAPP belongs to the MTC tether group
was based on accumulation of ER vesicles in a cell-free system
when TRAPP was depleted (Sacher et al., 2001). However, as
mentioned above, this can result from an indirect effect, e.g., due
to its GEF activity for Ypt1, which is required for recruitment of
the Golgi tethers. If TRAPP is a tether, it is expected to bridge a
distance>140 Å between two membranes. The length of TRAPP
complexes ranges between ∼180 Å for TRAPP I to ∼250 Å for
TRAPP II (Figure 1). Therefore, in principle, TRAPP complexes
could act as tethers, especially in potential cooperation with
other proteins. Like other known membrane tethers, TRAPP
complexes interact with GTPases. However, unlike all other
tethers, TRAPP complexes act as GEFs and not as downstream
effectors of GTPases. The interaction of GEFs with their GTPase
substrates is not stable and is interrupted once the GTPase binds
GTP. Thus, it is unlikely that TRAPP GEFs and Ypts together
create a bridge between two membranes. It is also not very likely
that TRAPP GEFs cooperate with Ypt/Rab effectors to create
membrane bridges, because the two bind to the two alternate
forms of the GTPases, GDP, and GTP, respectively.
In yeast, the interaction of Bet3, a core TRAPP subunit,
with Sec23, a component of the inner layer of COPII coat,
was shown to be required for TRAPP binding to ER-derived
vesicles (Cai et al., 2007). Interactions of TRAPP II and the
non-essential TRAPP II subunit Trs65 with components of the
COPI coat, Ret1/Cop1 and Gea2 (and Sec21), respectively, was
used to implicate TRAPP II in tethering of COPI vesicles to the
Golgi (Cai et al., 2005; Chen et al., 2011). In mammalian cells,
it was suggested that TRAPP II interacts with COPI vesicles,
the TRAPP II subunit TrappC9 interacts with a motor that
moves COP II vesicle on microtubules, and COPII vesicles were
suggested to interact with TRAPP III (Zong et al., 2012; Bassik
et al., 2013). In addition to the inconsistency between yeast and
mammalian cells, these findings provide information of TRAPP
interactions with one membrane, while as a bridge it is expected
to interact with two membranes. Interaction of the two Bet3
copies of a single TRAPP I complex with membranes of two
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separate vesicles was suggested to tether ER-derived vesicles
during their homotypic fusion (Cai et al., 2008). However, the
distance that one TRAPP I could bridge two membranes in
this model is ∼40 Å, which is shorter than a SNARE complex.
Moreover, homotypic fusion of ER vesicles has not been shown
in yeast, and the existence of TRAPP I in mammalian cells is
questionable. Therefore, evidence that any TRAPP complex acts
as a membrane tether is currently inconclusive.
To understand a possible mechanism by which TRAPP could
act as a membrane tether, it is crucial to know how TRAPP
complexes are positioned onmembranes. Currently, the topology
of TRAPP complexes on membranes is not known. TRAPP I
was proposed to lie flat on one membrane through its two Bet3
copies, which would yield a distance shorter than expected for a
tether. The idea that TRAPP I attaches to membranes through
Bet3 was based on its hydrophobic channel (Kim et al., 2006),
and/or palmitoylation. However, mutational analysis showed
that neither is needed for TRAPP I function (Cai et al., 2008).
The ways in which TRAPP II and TRAPP III are positioned
on membranes are also unknown. Thus, additional evidence
is needed to support the idea that TRAPP complexes act as
membrane tethers and to elucidate mechanisms by which they
might do that.
TRAPP IN DISEASE
Because the secretory pathway is implicated in a broad range
of human diseases (Aridor and Hannan, 2000), it was expected
that it would be similar for TRAPP, a complex key for transport
through the Golgi. Indeed, mutations in TRAPP subunits were
linked to a wide range of human diseases (Brunet and Sacher,
2014) and their number keeps growing. Here, we highlight new
disease connections (Table 1) and comment on the surprising
fact that different TRAPP subunits seem to be linked to different
diseases.
Examples of newly added disease connections for TRAPP
subunits include miscarriage for TrappC2 (Wen et al., 2015),
cancer for TrappC4 (Weng et al., 2014), and TrappC9
(Wetterskog et al., 2014; Zhang et al., 2015), intellectual disability
and schizophrenia for TrappC9 (Khattak and Mir, 2014;
McCarthy et al., 2014), and Alzheimer’s disease for TrappC6
(Hamilton et al., 2011; Chang et al., 2015).
If there is really only one mammalian TRAPP complex
(Barrowman et al., 2010), it is expected that mutations in
individual subunits would have overlapping effects. Therefore,
the most bewildering question about the involvement of TRAPP
in human disease is why mutations in individual subunits result
in such divergent diseases. One possible explanation is that there
is more than one human TRAPP complex with different tissue
specificities or cellular functions, and the different complexes
are involved in different diseases. Another possible explanation
is that “the screen is not saturated”; namely, the full range of
representative diseases for individual TRAPP subunits has not
been uncovered yet.
Recent findings connecting certain individual TRAPP
subunits to multiple diseases support this idea. For example,
only recently TrappC9 (Trs120) was connected to cancer and
schizophrenia in humans (Khattak and Mir, 2014; McCarthy
et al., 2014) and inflammatory disease in cows (Wang X.
et al., 2015), thus broadening its disease connection from the
previously known association with intellectual disability (Brunet
and Sacher, 2014). Likewise, Alzheimer’s disease was recently
added (Hamilton et al., 2011; Chang et al., 2015) to the previously
known association of TrappC6 (Trs33) with hypopigmentation
(Brunet and Sacher, 2014). Another example is the addition
of miscarriage (Wen et al., 2015) to the tissue specific disease
X-linked SEDL associated with TrappC2 (Trs20) (Brunet and
Sacher, 2014).
Recent findings also connect multiple TRAPP subunits to a
single disease. For example, to date four TRAPP subunits are
implicated in cancer: TrappC1 (Bet5), TrappC4 (Trs23) (Weng
et al., 2014), TrappC9 (Zhang et al., 2015), and TrappC10
(Pongor et al., 2015). Likewise, two TRAPP subunits were
recently implicated in brain-related diseases: TrappC6a (Trs33)
(Hamilton et al., 2011; Chang et al., 2015), TrappC9 (Khattak and
Mir, 2014; McCarthy et al., 2014).
Therefore, unless the disease divergence is due to
moonlighting activities of individual TRAPP subunits
unrelated to TRAPP, it is expected that association of individual
subunits with more diseases will be uncovered and that some
overlap between the different subunits, if not complete, will
emerge.
SUMMARY AND FUTURE QUESTIONS
While plenty of information has been accumulated about TRAPP
since its identification in yeast and mammalian cells and its
coming to the limelight as a Ypt/Rab GEF, there are still multiple
uncertainties and unanswered questions. Structure is known
only for the small TRAPP subunits, but not for the large ones.
Complex architecture is known for TRAPP I and to some extent
for TRAPP III, but not for TRAPP II. It is also not clear
whether dimerization of TRAPP II occurs in vivo and has a
function. It is not known whether the cellular functions of the
three known TRAPP complexes are conserved from yeast to
human cells. The Ypt/Rab GEF specificity of TRAPP complexes
is still under debate even in yeast. The topology of TRAPP
complexes on membranes is not known and evidence for a direct
role for TRAPP complexes in membrane tethering is lacking.
Finally, the apparent divergence of human disease associated
to different TRAPP subunits is unclear. Future experiments
will hopefully help fill in these multiple holes in the current
picture.
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